- Home
- REBN vs IBIO Comparison
REBN vs IBIO Comparison
Compare REBN & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REBN
- IBIO
- Stock Information
- Founded
- REBN 2015
- IBIO 2008
- Country
- REBN United States
- IBIO United States
- Employees
- REBN N/A
- IBIO N/A
- Industry
- REBN Restaurants
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- REBN Consumer Discretionary
- IBIO Health Care
- Exchange
- REBN Nasdaq
- IBIO Nasdaq
- Market Cap
- REBN 12.8M
- IBIO 11.9M
- IPO Year
- REBN 2022
- IBIO N/A
- Fundamental
- Price
- REBN $2.58
- IBIO $0.59
- Analyst Decision
- REBN
- IBIO Strong Buy
- Analyst Count
- REBN 0
- IBIO 2
- Target Price
- REBN N/A
- IBIO $5.50
- AVG Volume (30 Days)
- REBN 85.6K
- IBIO 432.7K
- Earning Date
- REBN 08-18-2025
- IBIO 09-19-2025
- Dividend Yield
- REBN N/A
- IBIO N/A
- EPS Growth
- REBN N/A
- IBIO N/A
- EPS
- REBN N/A
- IBIO N/A
- Revenue
- REBN $6,103,732.00
- IBIO $375,000.00
- Revenue This Year
- REBN $335.98
- IBIO $81.33
- Revenue Next Year
- REBN N/A
- IBIO N/A
- P/E Ratio
- REBN N/A
- IBIO N/A
- Revenue Growth
- REBN 3.38
- IBIO 650.00
- 52 Week Low
- REBN $1.03
- IBIO $0.56
- 52 Week High
- REBN $8.30
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- REBN 43.78
- IBIO 26.08
- Support Level
- REBN $2.50
- IBIO $0.56
- Resistance Level
- REBN $2.84
- IBIO $0.78
- Average True Range (ATR)
- REBN 0.20
- IBIO 0.03
- MACD
- REBN -0.02
- IBIO -0.01
- Stochastic Oscillator
- REBN 14.18
- IBIO 11.95
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.